Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Qiagen ( (QGEN) ) has provided an announcement.
Qiagen N.V. announced a release of voting rights information as notified by the Netherlands Authority for the Financial Markets (AFM). The notification, disclosed on the AFM website, details BlackRock, Inc.’s holdings in Qiagen, highlighting both real and potential voting rights and capital interests. This announcement could impact Qiagen’s market perception and stakeholder relations, given BlackRock’s significant involvement.
The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Qiagen N.V. operates in the biotechnology industry, specializing in providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company focuses on delivering solutions that enable customers to gain valuable insights from biological samples.
Average Trading Volume: 1,410,745
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.01B
For an in-depth examination of QGEN stock, go to TipRanks’ Overview page.